关于我们
BHI is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. It is a private-public partnership in the form of a 501 (c)(3) nonprofit that connects the Region’s innovation assets to provide integrated technical knowledge, financial means and entrepreneurial/managerial expertise to turn promise into prosperity for the region while advancing human health. BHI will accomplish its mission by building an entrepreneurial ecosystem, working directly with federal and academic technology transfer offices, making various types of risk capital readily available to promising biohealth startups, strengthening and connecting the local supply of industry talent, developing a regional brand and reputation, and advocating for improved business and regulatory conditions in the industry.
- 网站
-
https://www.biohealthinnovation.org
BioHealth Innovation, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Rockville,Maryland
- 类型
- 非营利机构
- 创立
- 2011
- 领域
- Entrepreneurship和Commercialization
地点
-
主要
1 Church St
US,Maryland,Rockville,20850
BioHealth Innovation, Inc.员工
动态
-
?? Exciting news! I’m honored to be a finalist for the 2024 RareVoice Awards, celebrating the voices that amplify rare disease advocacy. Join me on December 11 at the Ronald Reagan Building and International Trade Center in Washington, DC, for an unforgettable evening of inspiration and celebration. Let’s come together to honor all the finalists and awardees who are making a difference in the rare disease community. ??? Reserve your spot today: https://hubs.li/Q02ZbJn50 EveryLife Foundation for Rare Diseases Jeeva Clinical Trials Inc. Indo US Organization for Rare Diseases (IndoUSrare) I can’t wait to celebrate with you! #RareVoice2024
-
The latest BHI E-Newsletter is live with: ?? BHI team wishes everyone a warm and joyful Thanksgiving! ?? BioTalk with Eric Edwards, MD, PhD: MedPhlow’s innovative drug delivery systems are reshaping emergency medicine and improving outcomes in cardiac arrest situations. ?? Potomac's Versant Ventures Launches Pep2Tango Therapeutics: New startup aims to develop next-gen weight loss therapies using innovative tetra-receptor agonist peptides. ?? Biolojic Design, Ltd. Joins JLABS @ Washington: The AI-driven biotech company will collaborate with JLABS to advance its work on programmable, intelligent medicines. ?? IonQ Advances Hybrid Quantum Computing: Breakthrough in applying quantum computing to chemistry with the integration of NVIDIA CUDA-Q. ?? TearSolutions Inc. Secures $3M in Series B Funding: Funds will accelerate the development of therapies for rare corneal diseases at both pre-clinical and clinical stages. ?? TEDCO’s Entrepreneur Expo Introduces Concept Capital Pitch Competition: New competition highlights the importance of networking and capital for entrepreneurs at TEDCO’s annual event. ?? NAVIMED Capital Closes $450 Million Fund III: DC-based private equity firm raises funds for control growth transactions in healthcare. ??? BARDA Launches SPARK Hub Prize Challenge: Funding opportunity for innovators developing pediatric medical countermeasures to enhance health security for children. https://lnkd.in/e6hGKvT9
BioHealth Innovation Weekly for November 26, 2024
biohealthinnovation.org
-
Thank you BioHealth Innovation, Inc. and Richard Bendis for a great discussion on how Phlow’s subsidiary, MedPhlow, is working to transform essential medicine delivery.
??? Transforming Emergency Medicine: Eric Edwards, MD, PhD and MedPhlow’s Life-Saving Innovations on BioTalk In this episode, Dr. Eric Edwards, Co-Founder and CEO of MedPhlow, shares how his team is revolutionizing emergency medicine with groundbreaking drug delivery systems. As part of the BioHealth Capital Region, Dr. Edwards reflects on the ecosystem’s advantages and his contributions as a board member for BioHealth Innovation. Tune in to learn about the future of emergency medicine and MedPhlow's life-saving solutions. Discover how MedPhlow’s innovative platform is set to transform emergency care and how alliances with organizations like Virginia Venture Partners are driving this work forward. ?? Listen now: ?? Apple: https://apple.co/3Z7GqWf ?? Spotify: https://spoti.fi/3YYh6Sq ?? Amazon Music: https://amzn.to/4i16tXI ?? TuneIn: https://bit.ly/4hWAiJ7 From co-founding Phlow Corp. in 2019, working to repair the United States’ medicines shortages, to leading MedPhlow’s mission to improve outcomes in sudden cardiac arrest, Dr. Edwards is reshaping how essential medicines are delivered in emergencies. #BioHealthInnovation #EmergencyMedicine #MedTech #BioTalk #PharmaceuticalInnovation
-
??? Transforming Emergency Medicine: Eric Edwards, MD, PhD and MedPhlow’s Life-Saving Innovations on BioTalk In this episode, Dr. Eric Edwards, Co-Founder and CEO of MedPhlow, shares how his team is revolutionizing emergency medicine with groundbreaking drug delivery systems. As part of the BioHealth Capital Region, Dr. Edwards reflects on the ecosystem’s advantages and his contributions as a board member for BioHealth Innovation. Tune in to learn about the future of emergency medicine and MedPhlow's life-saving solutions. Discover how MedPhlow’s innovative platform is set to transform emergency care and how alliances with organizations like Virginia Venture Partners are driving this work forward. ?? Listen now: ?? Apple: https://apple.co/3Z7GqWf ?? Spotify: https://spoti.fi/3YYh6Sq ?? Amazon Music: https://amzn.to/4i16tXI ?? TuneIn: https://bit.ly/4hWAiJ7 From co-founding Phlow Corp. in 2019, working to repair the United States’ medicines shortages, to leading MedPhlow’s mission to improve outcomes in sudden cardiac arrest, Dr. Edwards is reshaping how essential medicines are delivered in emergencies. #BioHealthInnovation #EmergencyMedicine #MedTech #BioTalk #PharmaceuticalInnovation